Comprehensive virus catalogue reveals two to three new human-infective viruses are identified annually, highlighting ongoing pandemic risks and the need for sustained global surveillance
Launches include the first commercially available singleplex eMTBR-Tau immunoassay, a novel pTau 217 assay for venous and capillary blood, and a fully automated instrument platform
Roche will showcase new trontinemab clinical data, Phase III prevention studies, neuroinflammatory research, and blood-based Alzheimer’s diagnostics including Elecsys® pTau217 and pTau181
New Vericheck ddPCR™ kits bring validated, ready-to-use quality control assays to the QX700™ Digital PCR platform
New program to develop rapid diagnostic test for rare Bundibugyo Ebola strain during largest outbreak on record
Screening tools are becoming vital in the fight against Candida auris, a rapidly spreading and deadly fungal infection with growing antifungal resistance
Combining proteomics with multiomics workflows is helping researchers move beyond single markers and toward a more connected view of immune dysregulation, patient subtypes, and disease activity
Targeted proteomics platform company secures $7.5 million to scale commercialization and strategic partnerships
Assay enables laboratories across Europe and other CE-recognizing markets to scale blood-based Alzheimer’s disease testing and advance research into amyloid and tau pathology
Co-marketing agreement delivers end-to-end solution for DNA/RNA extraction and ultra-sensitive analysis
New system improves sample traceability and slide labeling in cancer diagnostics
FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling partner programs to run from immunisation to a developability-assessed lead in one continuous workflow
Learn how you can transform cell therapy screening workflows at all stages of research
